was successfully added to your cart.

Study: Trial of Cannabidiol for Drug-Resistant Seizures in Dravet Syndrome

Dravet Syndrome: The New England Journal of Medicine just released an exciting new study regarding the benefits of CBD in drug-resistant seizures in the Dravet Syndrome. In recent studies, CBD has shown to be a powerful agent against these seizure types, making this study a huge step in providing relief for thousands of people every day.

The study concluded with the patients with the Dravet syndrome, cannabidiol resulted in a greater reduction in convulsive-seizure frequency than placebo and was associated with higher rates of adverse events.

Read the full article

 

Dravet Syndrome is a type of epilepsy with seizures that are often triggered by hot temperatures or fever. Previously known as severe myoclonic epilepsy of infancy (SMEI), it affects 1:15,700 individuals, generally beginning in the first years of life.

How is Dravet Syndrome Treated?

Treatment involves finding the best combination of medicines to treat seizures and prevent seizure emergencies. Dietary therapy and vagus nerve stimulation can also be helpful.

Dravet syndrome is extremely resistant to treatment. In clinical studies, the most well documented and proven combination of drugs for Dravet syndrome include valproic acid, clobazam, and stiripentol (Diacomit).

But prescription medications come with a myriad of side effects. The most common side effects with Diacomit (seen in more than 1 in 10 patients) are loss of appetiteweight lossinsomnia (difficulty sleeping), drowsinessataxia(inability to co‑ordinate muscle movements), hypotonia (low muscle strength) and dystonia (muscle disorders).

CBD+Co’s cbd honey drops are made of all natural ingredients and pharmaceutical grade CBD isolate that has been upgraded to be water-soluble with revolutionary science and technology. This translates into fast, effective relief with NO SIDE EFFECTS.

Unlike many of the prescription treatments available, The US Department of Health and Human Services’ patent US6630507 states:

No signs of toxicity or serious side effects have been observed following chronic administration of cannabidiol to healthy volunteers (Cunha et al., Pharmacology 21:175-185, 1980), even in large acute doses of 700 mg/day “.

How is Dravet Syndrome Diagnosed?

In the 2015 study, clinical diagnostic criteria included at least 4 of the following:

  • Normal or near-normal cognitive and motor development before seizure onset
  • Two or more seizures with or without fever before 1 year of age
  • Seizure history consisting of myoclonic, hemiclonic, or generalized tonic-clonic seizures
  • Two or more seizures lasting longer than 10 minutes
  • Failure to respond to first-line antiepileptic drug therapy with continued seizures after 2 years of age

You can learn more about Dravet Syndrome from the Dravet Syndrome Foundation website.

You can order your own pharmaceutical-grade CBD Honey Drops HERE